MCID: MGR003
MIFTS: 52

Migraine with Aura malady

Category: Neuronal diseases

Aliases & Classifications for Migraine with Aura

About this section

Aliases & Descriptions for Migraine with Aura:

Name: Migraine with Aura 11 27 39 13 68
Migraine with Typical Aura 68
 
Classic Migraine 11

Classifications:



External Ids:

Disease Ontology11 DOID:10024
ICD9CM32 346.0
SNOMED-CT62 155047002, 4473006
MeSH39 D020325
NCIt45 C117005

Summaries for Migraine with Aura

About this section
Disease Ontology:11 A migraine characterized by migraine headache which is preceded or accompanied by a transient focal neurological phenomenon.

MalaCards based summary: Migraine with Aura, also known as migraine with typical aura, is related to migraine with aura 9 and migraine with aura 7, and has symptoms including headache, headache and headache. An important gene associated with Migraine with Aura is KCNK18 (Potassium Two Pore Domain Channel Subfamily K Member 18), and among its related pathways are Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics and Synaptic vesicle cycle. Affiliated tissues include brain, cortex and testes, and related mouse phenotypes are muscle and cardiovascular system.

Related Diseases for Migraine with Aura

About this section

Diseases in the Migraine with Aura family:

Migraine with Aura 9 Migraine with Aura 7

Diseases related to Migraine with Aura via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 95)
idRelated DiseaseScoreTop Affiliating Genes
1migraine with aura 912.1
2migraine with aura 712.1
3hemiplegic migraine11.3
4familial hemiplegic migraine11.3
5migraine, familial hemiplegic, 211.1
6migraine with or without aura 111.1
7migraine, familial hemiplegic, 111.1
8epilepsy, familial temporal lobe, 411.0
9migraine, familial hemiplegic, 311.0
10migraine, with or without aura 1311.0
11headache10.4
12cerebritis10.3
13patent foramen ovale10.3
14familial or sporadic hemiplegic migraine10.2
15intracranial cavernous angioma10.2DRD2, SLC6A4
16splenic abscess10.2DRD2, SLC6A4
17ornithosis10.2DRD2, SLC6A4
18dry eye syndrome10.2HTR2C, SLC6A4
19euthyroid sick syndrome10.2DRD2, SLC6A4
20kartagener syndrome10.2ACE, MTHFR
21pars planitis10.1ACE, MTHFR
22anodontia10.1HTR2C, SLC6A4
23apperceptive agnosia10.1DRD2, SLC6A4
24infantile hypotonia10.1ATP1A2, CACNA1A, EDNRA
25bullous skin disease10.1ACE, MTHFR
26renpenning syndrome10.1DBH, SLC6A4
27pyromania10.1DRD2, SLC6A4
28waardenburg's syndrome10.1DRD2, HTR2C, SLC6A4
29cecal benign neoplasm10.1DRD2, HTR2C, SLC6A4
30cholesteatoma10.1DRD2, HTR2C, SLC6A4
31restless legs syndrome10.1
32arteriovenous malformation10.1
33endotheliitis10.1
34microscopic colitis10.0ATP1A2, CACNA1A, NOTCH3
35retinoblastoma10.0DRD2, HTR2C, SLC6A4
36benign epilepsy with centrotemporal spikes10.0DRD2, HTR2C, SLC6A4
37personality disorder10.0DRD2, HTR2C, SLC6A4
38colorectal adenocarcinoma10.0DBH, DRD2, SLC6A4
39nephrogenic adenoma of the urethra10.0DBH, DRD2, SLC6A4
40cytomegalic congenital adrenal hypoplasia10.0DBH, DRD2, SLC6A4
41transmitted_by10.0DBH, DRD2, SLC6A4
42mucinous adenocarcinoma10.0DBH, DRD2, SLC6A4
43atrial fibrillation and stroke10.0ATP1A2, CACNA1A, PRRT2
44acro-pectoro-renal dysplasia10.0ATP1A2, CACNA1A, PRRT2
45placental abruption10.0ATP1A2, CACNA1A, PRRT2
46contagious pustular dermatitis9.9ACE, MTHFR, NOTCH3
47gaba aminotransferase deficiency9.9ATP1A2, PRRT2
48cervix small cell carcinoma9.9ACE, MTHFR, NOTCH3
49cadasil9.9
50cervicitis9.9

Comorbidity relations with Migraine with Aura via Phenotypic Disease Network (PDN):


Hypertension, EssentialTransient Cerebral Ischemia

Graphical network of the top 20 diseases related to Migraine with Aura:



Diseases related to migraine with aura

Symptoms & Phenotypes for Migraine with Aura

About this section

UMLS symptoms related to Migraine with Aura:


headache

MGI Mouse Phenotypes related to Migraine with Aura according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.6ATP1A2, CACNA1A, DRD2, EDNRA, HTR2C, NOTCH3
2MP:00053858.0ACE, ATP1A2, DBH, DRD2, EDNRA, NOTCH3
3MP:00053798.0ACE, CACNA1A, DBH, DRD2, EDNRA, NOTCH3
4MP:00107717.4ATP1A2, CACNA1A, DBH, DRD2, EDNRA, HTR2C
5MP:00028737.4ATP1A2, CACNA1A, DBH, DRD2, EDNRA, NOTCH3
6MP:00053787.2ACE, CACNA1A, DBH, DRD2, EDNRA, HTR2C
7MP:00053866.9ACE, ATP1A2, CACNA1A, DBH, DRD2, EDNRA
8MP:00053766.9ACE, ATP1A2, CACNA1A, DBH, DRD2, EDNRA
9MP:00107686.9ACE, ATP1A2, CACNA1A, DBH, DRD2, EDNRA
10MP:00036316.8ATP1A2, CACNA1A, DBH, DRD2, EDNRA, HTR2C

Drugs & Therapeutics for Migraine with Aura

About this section

Drugs for Migraine with Aura (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 171)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Naproxenapproved, vet_approvedPhase 4, Phase 325722204-53-11302, 156391
Synonyms:
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-(S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
(+)-(S)-Naproxen
(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionsaeure
(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German]
(+)-2-(Methoxy-2-naphthyl)-propionsäure
(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-Naproxen
(+)NAPROXEN
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
(S)-()-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-()-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-Naproxen
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid
(S)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-Naproxen
2-(6-Methoxy-2-naphthyl)propionic acid
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- (8CI)
22204-53-1
284785_ALDRICH
46482_FLUKA
46482_RIEDEL
65126_FLUKA
AC-1363
AC1L4G3X
AC1Q4ET9
AC1Q4F4H
AC1Q4F4I
ARONIS24306
Acusprain
Aleve
Anaprox
Anax
Anexopen
Apo-Napro-NA
Apo-Naproxen
Apronax
Artagen
Arthrisil
Artrixen
Artroxen
Atiflan
Axer
BIDD:GT0062
BRD-K59197931-001-02-9
BRD-K59197931-236-09-6
BSPBio_002067
Bipronyl
Bonyl
CAS-22204-53-1
CCRIS 5265
CG 3117
CHEBI:7476
CHEMBL154
CID156391
Calosen
Clinosyn
Congex
D-Naproxen
DB08298
DL Naproxen
DL-Naproxen
Danaprox
Daprox
Diocodal
DivK1c_000242
Duk
Dysmenalgit
Dysmenalgit N
EINECS 244-838-7
Ec-Naprosyn
Equiproxen
Equiproxen (Veterinary)
FT-0082415
Flanax Forte
Flexen
Flexipen
Floginax
Fuxen
Genoxen
HMS1920P13
HMS2089N21
HMS2091H12
HMS500M04
HSDB 3369
Headlon
IDI1_000242
InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
KBio1_000242
KBio2_001457
KBio2_004025
KBio2_006593
KBio3_001567
KBioGR_000597
KBioSS_001457
LS-124738
 
Laraflex
Lefaine
Leniartil
Lopac0_000792
M1021
Methoxypropiocin
MolPort-000-145-960
N8280_SIAL
NAPROXEN
NCGC00016759-01
NCGC00021127-01
NCGC00161591-01
NINDS_000242
NPS
Nafasol
Naixan
Nalyxan
Napflam
Napmel
Naposin
Napratec
Naprelan
Napren
Napren E
Naprius
Naprolag
Naprontag
Naprosin
Naprosyn LLE
Naprosyn LLE Forte
Naprosyne
Naproxen
Naproxen Sodium
Naproxen [USAN:BAN:INN:JAN]
Naproxene
Naproxene [INN-French]
Naproxeno
Naproxeno [INN-Spanish]
Naproxenum
Naproxenum [INN-Latin]
Naproxi 250
Naproxi 500
Naproxène
Napxen
Narma
Narocin
Naxen
Naxen F
Naxopren
Naxyn
Naxyn 250
Naxyn 500
Noflam
Novonaprox
Nycopren
Opipramol
Patxen
Prafena
Prestwick0_000791
Prestwick1_000791
Prestwick2_000791
Prestwick_349
Prexan
Priaxen
Pronaxen
Proxen LE
Proxen LLE
RS 3540
RS-3540
Rahsen
Reuxen
Rheumaflex
Roxen
SPBio_000966
SPBio_002861
SPECTRUM1500425
SR-01000075977-3
STOCK1N-50633
Saritilron
Sinartrin
Sinton
Soproxen
Spectrum2_001043
Spectrum3_000514
Spectrum4_000069
Spectrum5_001327
Spectrum_000977
Sutolin
Sutony
TL8003659
Tohexen
Traumox
U-Ritis
UNII-57Y76R9ATQ
UPCMLD-DP001
UPCMLD-DP001:001
Velsay
Veradol
Vinsen
Xenar
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German]
d-2-(6-Methoxy-2-naphthyl)propionic acid
d-Naproxen
2
MilnacipranapprovedPhase 45992623-85-365833
Synonyms:
( -)-Milnacipran
(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
(-)-milnacipran
(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl
105310-09-6
92623-85-3
AC1L2425
CHEMBL252923
CID65833
D08222
DB04896
F 2207
 
F-2207
F2207
Ixel
LS-178180
Midalcipran
Milnacipran
Milnacipran (INN)
Milnacipran [INN]
Milnacipranum
Milnacipranum [Latin]
Milnacipranum [latin]
NCGC00165825-01
Toledomin
UNII-G56VK1HF36
milnacipran
3
Sumatriptanapproved, investigationalPhase 4, Phase 3, Phase 2101103628-46-25358
Synonyms:
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide
1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide
103628-46-2
103628-48-4 (succinate)
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide
3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide
AC1L1K6B
Ambap103628-46-2
BIDD:GT0248
BRD-K50938287-001-01-7
BRN 6930870
BSPBio_002304
C07319
C14H21N3O2S
CHEBI:10650
CHEMBL128
CID5358
D00451
DB00669
GR 43175
GR 43175X
GR-43175
 
I06-0076
Imigran
Imigran (TN)
Imigran Recovery
Imitrex
Imitrex (TN)
Imitrex Oral
KS-1116
L000584
LS-83175
MLS001195659
MLS001304742
MolPort-002-885-863
NCGC00095838-01
NCGC00095838-02
NP101
SMR000596517
SPECTRUM1505372
Sumatran
Sumatriptan
Sumatriptan (JAN/USP/INN)
Sumatriptan Succinate
Sumatriptanum
Sumatriptanum [INN-Latin]
Sumatriptán
Sumax
UNII-8R78F6L9VO
estradiol
sumatriptan
triptan
4
Metoclopramideapproved, investigationalPhase 4, Phase 3120364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
 
KBio2_004686
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
5
Almotriptanapproved, investigationalPhase 4, Phase 313154323-57-6, 181183-52-8123606
Synonyms:
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
154323-57-6
AC1L3WYP
Almogran
Almotriptan
Almotriptan (USAN)
Almotriptan [USAN:INN:BAN]
Axert
BIDD:GT0048
BRD-K67601717-001-02-0
BSPBio_002731
C17H27N3O2S
CHEBI:520985
CHEMBL1505
CID123606
D02824
DB00918
HMS1922L13
I06-0492
KBio2_002408
KBio2_004976
 
KBio2_007544
KBio3_001951
KBioGR_001647
KBioSS_002414
L000846
LAS-31416
LS-173461
MolPort-003-666-604
N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine
N,N-dimethyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine
NCGC00095135-01
NCGC00095135-02
NCGC00095135-03
PNU-180638
SPBio_000395
SPECTRUM1505204
Spectrum2_000498
Spectrum3_001006
Spectrum4_001134
Spectrum5_001554
Spectrum_001884
UNII-1O4XL5SN61
6
KetorolacapprovedPhase 432374103-06-3, 66635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
7
Propranololapproved, investigationalPhase 4, Phase 2, Phase 3228525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
8
RizatriptanapprovedPhase 4, Phase 335145202-66-0, 144034-80-05078
Synonyms:
144034-80-0
AC-1712
AC1L1JK9
BIDD:GT0361
C093622
CHEBI:48273
CHEMBL905
CID5078
D08485
DB00953
I06-2272
L000812
LS-83053
MK 462 Free Base
MK 462 free base
MolPort-003-666-600
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
 
N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine
N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
NCGC00095899-01
Risatriptan
Rizatriptan
Rizatriptan (INN)
Rizatriptan [INN:BAN]
Rizatriptan benzoat
Rizatriptan benzoate
Rizatriptanum
Rizatriptán
SPECTRUM1505189
TL8000966
UNII-51086HBW8G
rizatriptan
rizatriptanum
9
Diclofenacapproved, vet_approvedPhase 4, Phase 332315307-86-53033
Synonyms:
(2,6-Dichlorophenyl)amino]benzeneacetic acid
15307-81-0 (mono-potassium salt)
15307-86-5
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-((2,6-dichlorophenyl)amino)benzeneacetic acid
2-(2,6-Dichloroanilino)phenylacetic Acid
2-(2,6-Dichlorophenylamino)phenylacetic acid
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid
2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
2-[2-(2,6-Dichlorophenylamino)phenyl]acetic acid
2-[2-(2,6-dichloroanilino)phenyl]acetic acid
2b17
AC1L1F0T
AKOS001579542
Acetic acid, [o-(2,6-dichloroanilino)phenyl]- (8CI)
Allvoran
Apo-Diclo
Assaren
BIDD:GT0380
BPBio1_000516
BRD-K08252256-236-05-6
BRN 2146636
BSPBio_000468
BSPBio_002169
Benfofen
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)- (9CI)
C01690
CHEBI:47381
CHEMBL139
CID3033
Cataflam
D07816
D30801
D3748
DB00586
DIF
Delphimix
Dichlofenac
Dichlofenal
Dichronic
Diclac
Diclo-Phlogont
Diclo-Puren
Diclobenin
Diclofenac (INN)
Diclofenac Acid
Diclofenac Potassium
Diclofenac Sodium
Diclofenac [INN:BAN]
Diclofenac acid
Diclofenaco
Diclofenaco [INN-Spanish]
Diclofenacum
Diclofenacum [INN-Latin]
Diclofenamic acid
Diclomelan
Diclonate P
Diclophenac
Diclord
Dicloreum
Dicloreuma
Dicrofenac
DivK1c_000272
DivK1c_000402
Dolobasan
Duravolten
Dyloject
EINECS 239-348-5
Ecofenac
Effekton
GP-45,840
HMS2090C10
HMS501E04
HSDB 7234
I14-7739
 
IDI1_000272
IDI1_000402
ISV-205
KBio1_000272
KBio1_000402
KBio2_001410
KBio2_002306
KBio2_003978
KBio2_004874
KBio2_006546
KBio2_007442
KBio3_001389
KBio3_002786
KBioGR_001051
KBioGR_002306
KBioSS_001410
KBioSS_002308
Kriplex
LS-11575
Lopac0_000441
MolPort-000-003-072
N-(2,6-Dichlorop
NCGC00021125-01
NINDS_000272
NINDS_000402
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Oprea1_011155
Orthofen
Pennsaid
Prestwick0_000594
Prestwick1_000594
Prestwick2_000594
Prestwick3_000594
Primofenac
ProSorb-D
Prophenatin
Rhumalgan
SBB068617
SPBio_001081
SPBio_002687
SR-38
STK984493
Solaraze
Solaraze (TN)
Solaraze T
Spectrum2_000991
Spectrum3_000385
Spectrum4_000506
Spectrum5_000867
Spectrum_000930
Transfenac
Tsudohmin
UNII-144O8QL0L1
UNM000001216103
Valetan
Voldal
Voltaflan
Voltaren
Voltaren Ophtha
Voltaren Ophthalmic
Voltaren Rapide
Voltaren SR
Voltaren ophthalmic
Voltaren-XR
Voltarol
Xenid
[2-(2,6-dichloroanilino)phenyl]acetic acid
[o-(2,6-Dichloroanilino)phenyl]acetic acid
cMAP_000014
dichlofenac
diclofenac
henyl)-o-aminophenylacetic acid
{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
10
Eletriptanapproved, investigationalPhase 4, Phase 319143322-58-177993
Synonyms:
(R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-Indole
(R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole
143322-58-1
3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole
3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole
5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
AB1004885
AC-3397
AC1L2U98
AKOS005145842
CHEBI:50922
CHEMBL1510
CID77993
D07887
 
DB00216
Eletriptan
Eletriptan (INN)
Eletriptan [INN:BAN]
Eletriptanum
LS-186998
LS-187637
MolPort-005-940-717
NCGC00181130-01
Relpax
UK 116044
UK-116044
UK-116044-04
UK116044
UNII-22QOO9B8KI
eletriptanum
11
Fentanylapproved, illicit, investigational, vet_approvedPhase 4821437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
12
TopiramateapprovedPhase 4, Phase 3, Phase 224997240-79-45284627
Synonyms:
-D-fructopyranose deriv.
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
CPD000466325
Cilag brand of topiramate
D00537
DB00273
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
MLS000759431
MLS001424070
McN 4853
McN-4853
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
 
Ortho brand of topiramate
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
STOCK1N-71037
Spectrum2_001128
T0575_SIGMA
TL8006021
TOR
TPM
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Topamac
Topamax
Topamax (TN)
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
UNII-0H73WJJ391
USL-255
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
topiramate
topiramate tablet
topiramatum [Latin]
13
DopamineapprovedPhase 4, Phase 3, Phase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
14Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 123689
15Serotonin 5-HT1 Receptor AgonistsPhase 4, Phase 3, Phase 2209
16Vasoconstrictor AgentsPhase 4, Phase 3, Phase 22122
17Vasodilator AgentsPhase 4, Phase 2, Phase 3, Early Phase 13543
18Serotonin AgentsPhase 4, Phase 3, Phase 23156
19Serotonin Uptake InhibitorsPhase 41587
20AnalgesicsPhase 4, Phase 3, Phase 211733
21
SerotoninPhase 4, Phase 3, Phase 2362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
22Psychotropic DrugsPhase 4, Phase 26430
23Antidepressive AgentsPhase 4, Phase 22736
24Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
25Neurotransmitter Uptake InhibitorsPhase 43521
26Cyclooxygenase InhibitorsPhase 4, Phase 3, Phase 22870
27Analgesics, Non-NarcoticPhase 4, Phase 3, Phase 26501
28Antirheumatic AgentsPhase 4, Phase 3, Phase 210956
29Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210729
30Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 3, Phase 24443
31Adrenergic AgentsPhase 4, Phase 2, Phase 35352
32NarcoticsPhase 43646
33Central Nervous System DepressantsPhase 4, Phase 3, Phase 213403
34Antihypertensive AgentsPhase 4, Phase 2, Phase 34207
35Adrenergic AntagonistsPhase 4, Phase 2, Phase 31573
36Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 33093
37Adrenergic beta-AntagonistsPhase 4, Phase 2, Phase 31193
38Pharmaceutical SolutionsPhase 48192
39Gastrointestinal AgentsPhase 4, Phase 3, Phase 28402
40Ketorolac TromethaminePhase 4323
41AnticonvulsantsPhase 4, Phase 3, Phase 22695
42Dopamine D2 Receptor AntagonistsPhase 4, Phase 3333
43Dopamine AntagonistsPhase 4, Phase 3, Phase 21093
44Autonomic AgentsPhase 4, Phase 3, Phase 2, Early Phase 110150
45Dopamine AgentsPhase 4, Phase 3, Phase 23836
46Anti-Obesity AgentsPhase 4, Phase 3, Phase 2413
47Neuroprotective AgentsPhase 4, Phase 3, Phase 2, Early Phase 11716
48AntiemeticsPhase 4, Phase 3, Phase 24022
49Anesthetics, GeneralPhase 42934
50AnestheticsPhase 4, Phase 39596

Interventional clinical trials:

(show top 50)    (show all 149)
idNameStatusNCT IDPhase
1Preventive Treatment of Episodic and Chronic MigraineUnknown statusNCT01319825Phase 4
2Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency DepartmentCompletedNCT01596166Phase 4
3Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCompletedNCT00210496Phase 4
4Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
5Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled TrialCompletedNCT02314351Phase 4
6Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year OldsCompletedNCT02287376Phase 4
7A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month PeriodCompletedNCT00792636Phase 4
8Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory DrugsCompletedNCT00634985Phase 4
9A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine HeadacheCompletedNCT00210509Phase 4
10An Efficacy and Tolerability Study of Topiramate in Participants With MigraineCompletedNCT01060111Phase 4
11Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.CompletedNCT00753311Phase 4
12Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and ImitrexCompletedNCT01450995Phase 4
13The Coherex FlatStent™ EF PFO Migraine RegistryUnknown statusNCT01280578Phase 3
14MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair ImplantUnknown statusNCT00283738Phase 2, Phase 3
15Acupuncture for Migraine ProphylaxisUnknown statusNCT01687660Phase 2, Phase 3
16Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With AuraCompletedNCT00449540Phase 3
17Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose StudyCompletedNCT01859481Phase 3
18Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With MigraineCompletedNCT00334178Phase 3
19Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for MigraineCompletedNCT01741714Phase 3
20Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine TreatmentCompletedNCT01814189Phase 3
21Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine HeadacheCompletedNCT00471952Phase 3
22Candesartan Versus Propranolol for Migraine PreventionCompletedNCT00884663Phase 2, Phase 3
23A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00236509Phase 3
24A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCompletedNCT00236561Phase 3
25A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00231595Phase 3
26Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic MigraineCompletedNCT00131443Phase 2, Phase 3
27Dysport® In Migraine Without Aura Prophylaxis : DIMWAP StudyCompletedNCT00258609Phase 3
28A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)CompletedNCT01004263Phase 3
29Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)CompletedNCT00442936Phase 3
30Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without AuraCompletedNCT01667679Phase 3
31TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)CompletedNCT00387881Phase 3
32Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack StudyCompletedNCT01986088Phase 3
33Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)CompletedNCT00483704Phase 3
34Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanCompletedNCT01989936Phase 3
35Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)CompletedNCT00443209Phase 3
36Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)CompletedNCT00432237Phase 3
37Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute MigraineCompletedNCT01978496Phase 3
38Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute MigraineCompletedNCT01462812Phase 3
39A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in AdolescentsCompletedNCT00210483Phase 3
40Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and PlaceboCompletedNCT01986270Phase 3
41An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackCompletedNCT00330850Phase 3
42A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)CompletedNCT00382993Phase 3
43A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)CompletedNCT00894556Phase 3
44A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)CompletedNCT00383162Phase 3
45Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of MigrainesCompletedNCT00122278Phase 3
46Migraine Study in Adolescent PatientsCompletedNCT00843024Phase 3
47Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of MigraineRecruitingNCT02828020Phase 3
48Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of MigraineRecruitingNCT02867709Phase 3
49Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral AGN-241689 in Episodic Migraine PreventionRecruitingNCT02848326Phase 2, Phase 3
50Efficacy, Tolerability, and Safety of DFN-15RecruitingNCT03009019Phase 3

Search NIH Clinical Center for Migraine with Aura


Cochrane evidence based reviews: migraine with aura

Genetic Tests for Migraine with Aura

About this section

Genetic tests related to Migraine with Aura:

id Genetic test Affiliating Genes
1 Migraine with Aura27

Anatomical Context for Migraine with Aura

About this section

MalaCards organs/tissues related to Migraine with Aura:

36
Brain, Cortex, Testes, Endothelial, Heart, Pituitary, Liver

Publications for Migraine with Aura

About this section

Articles related to Migraine with Aura:

(show top 50)    (show all 349)
idTitleAuthorsYear
1
Migraine with Aura or Sports-Related Concussion: Case Report, Pathophysiology, and Multidisciplinary Approach to Management. (28067735)
2017
2
Can the border of migraine with aura be safely extended? (27152015)
2016
3
Frequency of pediatric migraine with aura in a clinic-based sample. (26790850)
2016
4
Rare Complications of Migraine With Aura. (27400397)
2016
5
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. (26908949)
2016
6
The effect of 1A mg folic acid supplementation on clinical outcomes in female migraine with aura patients. (27339806)
2016
7
De Novo Migraine With Aura After Surgical Repair of Aortic Coarctation. (27910096)
2016
8
High leptin levels are associated with migraine with aura. (27165492)
2016
9
Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. (27930349)
2016
10
Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk? (27774589)
2016
11
Relationship between primary restless legs syndrome and migraine with aura. (27523456)
2016
12
Addenbrooke's cognitive examination test for brief cognitive assessment of adolescents suffering from migraine with aura. (27255917)
2016
13
White matter lesion burden in migraine with aura may be associated with reduced cerebral blood flow. (27177583)
2016
14
Transient Splenial Lesion of the Corpus Callosum Related to Migraine with Aura in a Pediatric Patient. (27526308)
2016
15
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. (27190013)
2016
16
Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura. (27238143)
2016
17
Endothelial function in migraine with aura - a systematic review. (25546573)
2015
18
Visual Snow in Migraine With Aura: Further Characterization by Brain Imaging, Electrophysiology, and Treatment - Case Report. (26307008)
2015
19
Reduced efficacy of sumatriptan in migraine with aura vs without aura. (25841032)
2015
20
Gene-based pleiotropy across migraine with aura and migraine without aura patient groups. (26660531)
2015
21
Increased interictal visual network connectivity in patients with migraine with aura. (25926619)
2015
22
Variability of clinical features in attacks of migraine with aura. (25944814)
2015
23
Cortical hot spots and labyrinths: why cortical neuromodulation for episodic migraine with aura should be personalized. (25798103)
2015
24
Statins for all: should patients who have migraine with aura be on a statin? (26500300)
2015
25
Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine. (25815319)
2015
26
Recurrence of Migraine With Aura After a 24-year Free Period Following rTMS Treatment for Fibromyalgia Pain. (26358488)
2015
27
Migraine with aura and patent foramen ovale: myth or reality? (26017514)
2015
28
Investigations of functional and structural changes in migraine with aura by magnetic resonance imaging. (26239598)
2015
29
Migraine with aura and TCD bubble-test: The significance of positive result. (26495697)
2015
30
No abnormalities of intrinsic brain connectivity in the interictal phase of migraine with aura. (25573335)
2015
31
Visual evoked potentials in subgroups of migraine with aura patients. (26527348)
2015
32
Reduced functional connectivity between salience and visual networks in migraine with aura. (25888585)
2015
33
Abnormal Connectivity Within Executive Resting-State Network in Migraine With Aura. (26084236)
2015
34
Incidences of aortic and mitral valve strands in patients with migraine with aura. (25936701)
2015
35
Migraine with aura: which patients are most at risk of stroke? (26017513)
2015
36
Efficacy of frovatriptan as compared to other triptans in migraine with aura. (25916333)
2015
37
Our evolving understanding of migraine with aura. (25230799)
2014
38
Impaired visual inhibition in migraine with aura. (25586129)
2014
39
Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy. (24948446)
2014
40
Multimodal assessment of optokinetic visual stimulation response in migraine with aura. (23980899)
2014
41
Retinal nerve fibre layer, ganglion cell layer and choroid thinning in migraine with aura. (24885597)
2014
42
Framing comorbidities and co-occurrences in a migraine with aura patient. (24852063)
2014
43
Perfusion patterns in migraine with aura. (24554619)
2014
44
A challenging multifactorial migraine with aura. (24419740)
2014
45
Circulating microparticles in migraine with aura: Cause or consequence, a link to stroke. (24715499)
2014
46
The effects of topiramate therapy on cerebral metabolism in migraine with aura patients. (25269040)
2014
47
Association between serum levels of homocysteine with characteristics of migraine attacks in migraine with aura. (25657748)
2014
48
Migraine with aura is associated with impaired colour vision: Results from the cross-sectional German DMKG headache study. (25179294)
2014
49
Should women suffering from migraine with aura be screened for biological thrombophilia?: results from a cross-sectional French study. (24530211)
2014
50
Acetylsalicylic Acid in migraine with aura prevention - a retrospective study. (25729594)
2014

Variations for Migraine with Aura

About this section

Expression for genes affiliated with Migraine with Aura

About this section
Search GEO for disease gene expression data for Migraine with Aura.

Pathways for genes affiliated with Migraine with Aura

About this section

GO Terms for genes affiliated with Migraine with Aura

About this section

Cellular components related to Migraine with Aura according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1integral component of membraneGO:00160216.7ACE, ATP1A2, CACNA1A, DBH, DRD2, EDNRA
2plasma membraneGO:00058866.6ACE, ATP1A2, CACNA1A, DRD2, EDNRA, HTR2C
3membraneGO:00160206.6ACE, ATP1A2, CACNA1A, DBH, DRD2, EDNRA

Biological processes related to Migraine with Aura according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1adult walking behaviorGO:000762810.5CACNA1A, DRD2
2negative regulation of cytosolic calcium ion concentrationGO:005148110.5ATP1A2, DRD2
3neuron-neuron synaptic transmissionGO:000727010.5CACNA1A, DRD2
4regulation of vasoconstrictionGO:001922910.4ACE, ATP1A2
5release of sequestered calcium ion into cytosolGO:005120910.3DRD2, HTR2C
6arachidonic acid secretionGO:005048210.3ACE, DRD2
7associative learningGO:000830610.0DBH, DRD2
8behavioral response to ethanolGO:004814910.0DBH, DRD2
9response to amphetamineGO:00019759.9DBH, DRD2
10vasoconstrictionGO:00423109.9EDNRA, SLC6A4
11response to painGO:00482659.9CACNA1A, DBH
12blood vessel remodelingGO:00019749.8ACE, DBH
13regulation of blood pressureGO:00082179.7ACE, ATP1A2, EDNRA
14response to drugGO:00424939.5DRD2, HTR2C, MTHFR, SLC6A4
15locomotory behaviorGO:00076269.5DBH, DRD2, HTR2C
16response to hypoxiaGO:00016669.3DRD2, EDNRA, MTHFR, SLC6A4
17visual learningGO:00085429.0ATP1A2, DBH, DRD2

Molecular functions related to Migraine with Aura according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1drug bindingGO:00081448.9ACE, ATP1A2, DRD2, HTR2C

Sources for Migraine with Aura

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet